Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SyntheMed, a biomaterials company, has received the FDA 510(k) clearance to market SinusShield, a bioresorbable membrane intended to prevent post-operative adhesions in nasal and sinus surgical procedures.
Subscribe to our email newsletter
Robert Hickey, president and CEO of SyntheMed, said: “SinusShield represents an example of our strategy to capitalize on our proprietary polymer film technology in new surgical applications both in the US and international markets.
“The company is in discussion with prospective partners with the distribution infrastructure to service the office-based and hospital outpatient sites where these procedures are performed.”